Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study

Schernthaner, G.; Rosas-Guzman, J.; Dotta, F.; Guerci, B.; Simo, R.; Festa, A.; Kiljanski, J.; Zhou, M.; Gallwitz, B.

dc.contributor.author	Gallwitz, Baptist
dc.date.accessioned	2015-10-01T12:50:34Z
dc.date.available	2015-10-01T12:50:34Z
dc.date.issued	2015
dc.identifier.issn	1462-8902
dc.identifier.uri	http://hdl.handle.net/10900/65249
dc.language.iso	en	en
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.12471	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_00266
utue.publikation.seiten	689-698	de_DE
utue.personen.roh	Schernthaner, G.
utue.personen.roh	Rosas-Guzman, J.
utue.personen.roh	Dotta, F.
utue.personen.roh	Guerci, B.
utue.personen.roh	Simo, R.
utue.personen.roh	Festa, A.
utue.personen.roh	Kiljanski, J.
utue.personen.roh	Zhou, M.
utue.personen.roh	Gallwitz, B.
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE